Literature DB >> 23065500

Usefulness of contrast-enhanced intraoperative ultrasonography (CE-IOUS) in patients with colorectal liver metastases after preoperative chemotherapy.

Andrea Ruzzenente1, Simone Conci, Calogero Iacono, Alessandro Valdegamberi, Tommaso Campagnaro, Francesca Bertuzzo, Fabio Bagante, Michela De Angelis, Alfredo Guglielmi.   

Abstract

AIMS: The aim of this study was to evaluate the ability of contrast-enhanced intraoperative ultrasonography to detect colorectal liver metastases after preoperative chemotherapy compared with intraoperative ultrasound and preoperative imaging techniques.
METHODS: From January 2010 to December 2011, 28 patients with colorectal liver metastases underwent intraoperative ultrasonography and contrast-enhanced intraoperative ultrasonography during hepatectomy following preoperative chemotherapy. The findings were compared to preoperative imaging using contrast-enhanced ultrasonography, computed tomography, magnetic resonance imaging, and/or fluorodeoxyglucose positron emission tomography.
RESULTS: Preoperative imaging techniques detected 58 metastatic lesions in 28 patients. In 32 % of patients (n = 9), intraoperative ultrasound detected 24 missed hepatic nodules. In 14 % of patients (n = 4), contrast-enhanced intraoperative ultrasonography detected an additional six nodules and change in operative management occurred in 18 % of patients. Using univariate analysis, we found three factors significantly related to detection of additional metastases with contrast-enhanced intraoperative ultrasonography: three or more metastases before chemotherapy (p = 0.047), resolution of at least one metastasis (p = 0.011), and small liver metastases (largest lesion size ≤20 mm) after chemotherapy (p = 0.007).
CONCLUSION: In patients undergoing surgery for colorectal liver metastases after chemotherapy, contrast-enhanced intraoperative ultrasonography improved both the sensitivity of intraoperative ultrasonography to detect liver metastases and the R0 hepatic resection rate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065500     DOI: 10.1007/s11605-012-2043-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis.

Authors:  J Schmidt; M Strotzer; S Fraunhofer; H Boedeker; H Zirngibl
Journal:  World J Surg       Date:  2000-01       Impact factor: 3.352

Review 2.  The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "medical" articles in the European Spine Journal, 2005.

Authors:  Michel Benoist
Journal:  Eur Spine J       Date:  2006-01-13       Impact factor: 3.134

3.  Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?

Authors:  Edward Leen; Piercarlo Ceccotti; Susan J Moug; Paul Glen; John MacQuarrie; Wilson J Angerson; Thomas Albrecht; Joachim Hohmann; Anja Oldenburg; Jorg Peter Ritz; Paul G Horgan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

4.  Accuracy of multislice liver CT and MRI for preoperative assessment of colorectal liver metastases after neoadjuvant chemotherapy.

Authors:  C S van Kessel; M S van Leeuwen; M A A J van den Bosch; I H M Borel Rinkes; W P T M Mali; P Westers; R van Hillegersberg
Journal:  Dig Surg       Date:  2011-02-04       Impact factor: 2.588

Review 5.  Cancer of the colon and rectum: current concepts of aetiology and pathogenesis.

Authors:  M J O'Brien
Journal:  Ir J Med Sci       Date:  1988-07       Impact factor: 1.568

6.  Preoperative detection of colorectal liver metastases in fatty liver: MDCT or MRI?

Authors:  Vanessa Kulemann; Wolfgang Schima; Dietmar Tamandl; Klaus Kaczirek; Thomas Gruenberger; Friedrich Wrba; Michael Weber; Ahmed Ba-Ssalamah
Journal:  Eur J Radiol       Date:  2010-04-13       Impact factor: 3.528

7.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

8.  Disappearing colorectal liver metastases after chemotherapy: should we be concerned?

Authors:  Mark G van Vledder; Mechteld C de Jong; Timothy M Pawlik; Richard D Schulick; Luis A Diaz; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2010-09-14       Impact factor: 3.452

Review 9.  Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

Authors:  D Zorzi; A Laurent; T M Pawlik; G Y Lauwers; J-N Vauthey; E K Abdalla
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

10.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316

View more
  12 in total

1.  Is intraoperative ultrasound still useful for the detection of colorectal cancer liver metastases?

Authors:  Guillaume Hoch; Valérie Croise-Laurent; Adeline Germain; Laurent Brunaud; Laurent Bresler; Ahmet Ayav
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

2.  Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience.

Authors:  Dimitrios Ntourakis; Ricardo Memeo; Luc Soler; Jacques Marescaux; Didier Mutter; Patrick Pessaux
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

Review 3.  Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases.

Authors:  Fernando A Alvarez; Rodrigo Sanchez Claria; Sebastian Oggero; Eduardo de Santibañes
Journal:  World J Gastrointest Surg       Date:  2016-06-27

4.  Intraoperative Contrast-Enhanced Ultrasound in Colorectal Liver Metastasis Surgery Improves the Identification and Characterization of Nodules.

Authors:  Julien Hoareau; Aurélien Venara; Jérôme Lebigot; Jean-Francois Hamel; Emilie Lermite; Francois Xavier Caroli-Bosc; Christophe Aube
Journal:  World J Surg       Date:  2016-01       Impact factor: 3.352

Review 5.  Update on the role of imaging in management of metastatic colorectal cancer.

Authors:  Sree Harsha Tirumani; Kyung Won Kim; Mizuki Nishino; Stephanie A Howard; Katherine M Krajewski; Jyothi P Jagannathan; James M Cleary; Nikhil H Ramaiya; Atul B Shinagare
Journal:  Radiographics       Date:  2014 Nov-Dec       Impact factor: 5.333

6.  Improved sensitivity and positive predictive value of contrast-enhanced intraoperative ultrasound in colorectal cancer liver metastasis: a systematic review and meta-analysis.

Authors:  Jun-Yao Chen; Hui-Yong Dai; Cai-Yang Li; Ying Jin; Ling-Ling Zhu; Tian-Fei Zhang; Yan-Xia Zhang; Wen-Hao Mai
Journal:  J Gastrointest Oncol       Date:  2022-02

7.  Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities.

Authors:  Christian Sturesson; Jan Nilsson; Gert Lindell; Roland G Andersson; Inger Keussen
Journal:  HPB (Oxford)       Date:  2015-08-07       Impact factor: 3.647

8.  A meta-analysis evaluating contrast-enhanced intraoperative ultrasound (CE-IOUS) in the context of surgery for colorectal liver metastases.

Authors:  Maria P Fergadi; Dimitrios E Magouliotis; Marianna Vlychou; Christos Rountas; Thanos Athanasiou; Dimitrios Zacharoulis
Journal:  Abdom Radiol (NY)       Date:  2021-05-09

Review 9.  The role of intraoperative ultrasonography in the diagnosis and management of focal hepatic lesions.

Authors:  Ijin Joo
Journal:  Ultrasonography       Date:  2015-04-06

Review 10.  Current role of intraoperative ultrasonography in hepatectomy.

Authors:  Toshiya Kamiyama; Tatsuhiko Kakisaka; Tatsuya Orimo
Journal:  Surg Today       Date:  2021-01-04       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.